GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (FRA:20B) » Definitions » Pretax Margin %

Biomark Diagnostics (FRA:20B) Pretax Margin % : -958.62% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Biomark Diagnostics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Biomark Diagnostics's Pre-Tax Income for the three months ended in Dec. 2023 was €-0.28 Mil. Biomark Diagnostics's Revenue for the three months ended in Dec. 2023 was €0.03 Mil. Therefore, Biomark Diagnostics's pretax margin for the quarter that ended in Dec. 2023 was -958.62%.

The historical rank and industry rank for Biomark Diagnostics's Pretax Margin % or its related term are showing as below:

FRA:20B' s Pretax Margin % Range Over the Past 10 Years
Min: -3304.55   Med: -1203.92   Max: -461.98
Current: -940.24


FRA:20B's Pretax Margin % is ranked worse than
90.83% of 218 companies
in the Medical Diagnostics & Research industry
Industry Median: -13.725 vs FRA:20B: -940.24

Biomark Diagnostics Pretax Margin % Historical Data

The historical data trend for Biomark Diagnostics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Pretax Margin % Chart

Biomark Diagnostics Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -463.53 - -3,259.38 -1,208.65

Biomark Diagnostics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,053.85 -1,270.37 -1,039.29 -510.34 -958.62

Competitive Comparison of Biomark Diagnostics's Pretax Margin %

For the Diagnostics & Research subindustry, Biomark Diagnostics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biomark Diagnostics's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Biomark Diagnostics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Biomark Diagnostics's Pretax Margin % falls into.



Biomark Diagnostics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Biomark Diagnostics's Pretax Margin for the fiscal year that ended in Mar. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=-1.257/0.104
=-1,208.65 %

Biomark Diagnostics's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-0.278/0.029
=-958.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biomark Diagnostics  (FRA:20B) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Biomark Diagnostics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biomark Diagnostics (FRA:20B) Business Description

Traded in Other Exchanges
Address
130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2
Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Biomark Diagnostics (FRA:20B) Headlines

No Headlines